Discontinued drugs in 2012: oncology drugs

Gatekeepers and Enablers: How Drug Regulators Respond to a Challenging and Changing Environment by Moving Toward a Proactive Attitude

(2013) F Ehmann et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

2012 FDA drug approvals

(2013) Asher Mullard   NATURE REVIEWS DRUG DISCOVERY

Discontinued drugs in 2011: oncology drugs

(2012) Robert Williams   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Clinical Cancer Advances 2012: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

(2012) Bruce J. Roth et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase I trials of targeted anticancer drugs: a need to refocus

(2012) Ernest C. Borden et al.   NATURE REVIEWS DRUG DISCOVERY

Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival

(2011) Paul Morgan et al.   DRUG DISCOVERY TODAY